U-Dream is an over-the-counter sleep aid product that was manufactured and/or distributed by Biotrade Canada Ltd., London Drugs Limited, Rexall Pharmacy Group Ltd., Rexall/Pharma Plus Pharmacies Ltd., Whole Foods Market, Whole Foods Market Canada Inc. and PNP Pharmaceuticals Inc (the “Defendants”) in Canada.
The Plaintiff alleges that U-Dream was contaminated by an undisclosed ingredient and should never have been sold. Further, the Plaintiff alleges that it caused some Class Members to sustain injuries.
TopSettlement Funds of approximately $2,734,485 (after legal fees, claims administration costs and disbursements are deducted) are available to pay all eligible claimants, known as Class Members, who make a claim.
TopThe Class consists of:
a) all persons in Canada who purchased or ingested U-Dream between August 18, 2014 to present; and
b) where such persons in (a) are deceased, all living parents, spouses or children entitled to maintain a claim against the Defendants pursuant to the Family Compensation Act, R.S.B.C. 1996, c. 126, and persons entitled to bring similar claims in other Provinces and Territories.
TopYou must fully complete the Court-approved online or paper Claim Form.
Important: The deadline for making a claim is March 3, 2025.
All claims must be received by the Claims Administrator, NO LATER THAN 120 days after the settlement of the Class Action was approved, or March 3, 2025. If a paper Claim Form is used, the postmark on the envelope will be considered as the day the Claim Form was submitted to the Claims Administrator.
TopClass Counsel Fees of 30% plus PST and GST (12%) on Compensatory Payments to Plaintiff and Class Members; and Class Counsel Fees of 15% plus GST and PST (12%) on Public Health Insurer Payments, 75% of which is to be paid as a first charge on the Settlement Funds after the Effective Date, and the balance, subject to approval of the Court, following delivery of the Final Report by the Claims Administrator.
Top